Example: Heart Attack

Search clinical trials for: Pioglitazone

Total 420 results

NCT03109288

Recruiting

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

Conditions: Multiple Sclerosis
NCT03566225

Completed

Pioglitazone Versus Metformin as First Treatment in Infertile Women With Polycystic Ovary Syndrome

Conditions: Pioglitazone
NCT02917629

Terminated

ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment

Conditions: Oral Cavity Neoplasm, Oropharyngeal Neoplasm, Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7, Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7, Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
NCT00571519

Terminated

Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes Mellitus
NCT00904046

Recruiting

Pathophysiology of Uric Acid Nephrolithiasis

Conditions: Uric Acid Kidney Stone Disease
NCT00745225

Completed

Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients

Conditions: End-stage Renal Disease
NCT04885712

Recruiting

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Conditions: Type2 Diabetes
NCT01135394

Completed

Pharmacogenomics of Thiazolidinediones

Conditions: Type 2 Diabetes
NCT04370093

Recruiting

Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss

Conditions: Nephrolithiasis, Uric Acid
NCT00720577

Completed

Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.

Conditions: Peripheral Arterial Disease
NCT04883125

Completed

Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment

Conditions: Chronic Myelogenous Leukemia, BCR-ABL Positive, CML, Chronic Phase
NCT00143520

Completed

Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes

Conditions: Type 2 Diabetes
NCT04867252

Not yet recruiting

Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

Conditions: PCOS
NCT01748994

Completed

Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women

Conditions: Obesity, Metabolic Syndrome
NCT03910361

Completed

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Conditions: Type2 Diabetes, Non-Alcoholic Fatty Liver Disease
NCT04843046

Not yet recruiting

Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

Conditions: Cocaine Use Disorder
NCT02879409

Active, not recruiting

HbA1c Variability in Type II Diabetes

Conditions: Diabetes Mellitus Type 2
NCT04662866

Recruiting

Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose

Conditions: Impaired Glucose Tolerance, Insulin Sensitivity, Glucose Metabolism Disorders
NCT02592317

Active, not recruiting

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Conditions: Prostatic Neoplasms, Castration-Resistant
NCT04658849

Recruiting

Insulin Resistance Following ADT for Prostate CA

Conditions: Insulin Resistance, Prostate Cancer
NCT03060772

Suspended

A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)

Conditions: Alcoholism
NCT04604223

Recruiting

Effect of Pioglitazone on T2DM Patients With COVID-19

Conditions: Covid19, Type 2 Diabetes
NCT04794127

Not yet recruiting

Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.

Conditions: Liposarcoma, Myxoid, Liposarcoma, Dedifferentiated, Liposarcoma, Round Cell
NCT01107717

Active, not recruiting

Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

Conditions: Diabetes
NCT01838317

Completed

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

Conditions: Cancer of the Pancreas